Precision Medicine

California-based genomics company talks saving lives, research.
A 13-point jump from last year’s Society of Actuaries survey.
Bioimpedance spectroscopy (BIS) technology could make difference.
Real-world data seen as supporting clinical and regulatory decisions.
Gene replacement could stop the progression of dilated cardiomyopathy.
The software has since been patched, but the weakness could have left individuals’ genomic data vulnerable.
Providers could have the opportunity to administer the innovative cancer therapy to improve patient outcomes.
How health systems can construct an effective strategic plan for innovation.
A closer look at the research collaboration between Cota and the FDA.
The agency will continue developing frameworks to look at the benefits and risks of cutting-edge technologies.

The Inside Digital Health Precision Medicine page serves as a source of all the latest information, with articles covering approaches to care that permit physicians to treat their patients based on specific genetic data. Here, readers will find news from conferences and annual meetings pertaining to precision medicine, including pivotal coverage right from the floor.

Among its other resources are in-depth articles and a wealth of videos, including interviews with thought leaders and experts in the space, and moderated panel discussions about genomic data, the best practices and key methods for treating complex cases, utilizing the newest therapies, examining the issues and challenges of implementing technology into healthcare, and more.

Become a contributor